TCL, a leading consumer electronics brand based in China, has unveiled a Mini LED TV for the Indian market, heralding its technical innovation in the TV segment. According to sources, the company’s small LED QLED 4K Android 11 TV C825 will be available in 55-inch and 65-inch panel sizes, with prices ranging fro
L&T Technology Services Limited, a pioneer in pure-play engineering services, recently announced a strategic collaboration with Mavenir to offer integrated 5G automation services and Open RAN.
Reports suggest that the automation services is likely to include Continuous Integra
NXP Semiconductors, a Dutch semiconductor manufacturer and RILs Jio Platforms Ltd. (JPL) have announced a partnership to develop 5G NR O-RAN small cells using NXPs Layerscape multicore processors family.
The integrated solution will enable a wide range of 5G use cases for internet
Indian online pharm
Abu Dhabi Investment Authority, the UAE’s autonomous wealth fund, has recently and exclusively announced taking over a minority share in India’s digital payments application- MobiKwik for Rs 150 crore, valuing the company at Rs 5,193 crore.
It has been reported that th
Accepti.inc, a technology-enabled lender has reportedly raised $90 million in debt and equity funding to enhance its digital mortgage lending platform where $78 million is in debt and $12 million is in equity. The equity part of the funding was reportedly led by SignalFire, along with its existing investors - DN Capi
The company has entered into the market with a ground-breaking approach to detect cancer and other diseases
Disease diagnostic company, Adela has raised $60 million in a Series A funding round with aim to use this investment to develop a blood test that can detec
The ongoing trend of vehicle electrification is now set to have a major impact on the automobile space in India. Audi India recently revealed that its next big launch in the country would be e-tron SUV, which is expected to hit the roads soon.
Reports suggest that the battery-powe
Bharat Biotech International Limited has reportedly submitted the data from Covaxin’s Phase 3 clinical trial to the Drugs Controller General of India (DCGI). If the Indian regulator approves the data, the Bangalore-based biotechnology firm will then be able to apply for WHO approval.